NDC codes

FDA NDC Directory
Product NDC (as listed)47335-303Labeler and product segments. Claims need a package NDC.
Product NDC at billing width47335-0303Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
47335-303-15473350303154733503031530 CAPSULE in 1 BOTTLE (47335-303-15)Marketed from Sep 21, 2017
47335-303-83473350303834733503038330 CAPSULE in 1 BOTTLE (47335-303-83)Marketed from Sep 21, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Odomzo
Generic name (nonproprietary)
sonidegib
Active ingredients
Sonidegib phosphate — 200 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Sun Pharmaceutical Industries, Inc.NDC labeler code 47335
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication NDA 205266
Marketing start
Listing expires
Other FDA classes
Smoothened Receptor Antagonists (Mechanism)
Identifiers
Product ID 47335-303_001dc6f2-7476-4ffd-8ea4-be2f97a2b6b3SPL ID 001dc6f2-7476-4ffd-8ea4-be2f97a2b6b3SPL set ID 028312dc-d155-4fd5-8abd-6bb9f011d3ccRxCUI 1659921, 1659927UNII W421AI34UW
Pharmacologic class
Hedgehog Pathway Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N447335030315 followed by a unit qualifier and the quantity

Package 47335-0303-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

ODOMZO (sonidegib) is indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. ODOMZO is a hedgehog pathway inhibitor indicated for the treatment of adult patients with locally advanced basal cell carcinoma (BCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 47335-303

What is NDC 47335-303?
47335-303 is the product NDC for Odomzo (sonidegib), Sonidegib phosphate 200 mg/1 capsule, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Odomzo (Sonidegib).
What is the active ingredient?
Sonidegib phosphate.
Who is the labeler?
Sun Pharmaceutical Industries, Inc., NDC labeler code 47335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Odomzo?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in